Friedrich Miescher Institute for Biomedical Research

Friedrich Miescher Institute for Biomedical Research
Friedrich Miescher Institute for Biomedical Research  
Location: Basel
Discipline: Medicine/Pharmacology
Affiliation: Novartis

Understanding the mechanisms of disease

The Friedrich Miescher Institute is devoted to fundamental biomedical research aimed at understanding the basic molecular mechanisms of health and disease. We communicate and patent our findings to enable their translation into medical application. The FMI focuses on the fields of
  • Epigenetics
  • Growth control
  • Neurobiology
In these fields, the FMI has gained international recognition as a center of excellence in innovative biomedical research.

Training young scientists

Life Sciences - Jan 20, 2017
Helge Großhans and his group at the Friedrich Miescher Institute for Biomedical Research (FMI) have elucidated the mode of action of the RNA-binding protein and stem cell factor LIN41. In an animal model, they showed that LIN41 silences four specific mRNAs, by two distinct mechanisms. They found that the choice of mechanism is determined by where on the mRNA LIN41 binds.
Life Sciences - Oct 21, 2016
Life Sciences

Scientists in the group of Andreas Lüthi have identified two neuronal circuits that mediate the association of contextual information with emotional memories.

Life Sciences - Jan 26, 2016

Understanding learning and memory processes is of fundamental importance to the study of brain function and provides valuable insights for disorders where these processes are disturbed.

Medicine - Aug 12, 2015

Understanding how different cell populations arise within a tumor - so-called tumor heterogeneity - is widely regarded as a major challenge for cancer biology.

Life Sciences - May 2, 2016
Life Sciences

One of the fundamental questions in neuroscience is how neuronal circuits are wired to process information.

Life Sciences - Jan 19, 2016

A better knowledge of RNA metabolism is key to understanding how RNAs regulate development and differentiation, and how their malfunction leads to disease.

Life Sciences - Jun 18, 2015

Andreas Lüthi, Botond Roska, Dirk Schübeler and Nicolas Thomä, leading scientists at the Friedrich Miescher Institute for Biomedical Research in Basel, will each receive one of the prestigious ERC Advanced Grants from the European Research Council (ERC).

website preview


Medicine and Life Sciences